NCT06034782

Brief Summary

Tumors of the salivary glands occupy 0.5-1.2% of cases of head and neck tumors. They are primarily a surgical disease, as their treatment is basically the surgical excision. In this direction and in the context of the differential preoperative diagnosis, in addition to the imaging methods, the fine needle biopsy (FNA) was used, with which cell material is aspirated from the tumor and studied under the microscope. Although an increasing number of papers have been published in the international scientific literature over the last 5 years on the diagnostic accuracy of FNA in salivary glands, many of them are unable to quantify and omit to refer information that could affect the estimated diagnostic accuracy. Such information is for instance the clinical experience of the doctor who performs the FNA and of the one who assess the smear. The aim of this retrospective study is to evaluate the diagnostic accuracy of fine needle biopsy in adult patients with salivary gland tumor that underwent a surgical excision in two Oral and Maxillofacial Departments in Northern Greece. The present retrospective study was carried out from 2/2021 to 4/2022 by collecting data from the files of patients who underwent surgery at the Oral and Maxillofacial Clinic of the Theageneio Cancer Hospital of Thessaloniki 1996-2022 and the General Hospital of Thessaloniki G. Papanikolaou 2015-2022. The study was conducted according to the STARD 2015 protocol. FNA contributed significantly to the differential preoperative process in salivary gland diseases. The differential diagnosis of a lesion in benign / malignant preoperatively, with the use of FNA, enables the surgeon for a more beneficial to the patient and oncologically safer planning of the surgery. It is considered important the high sensitivity provided by the examination, as it helps to exclude with sufficient safety the possible malignancy of the tumor located in the salivary gland of the patient.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
128

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 22, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2022

Completed
22 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 6, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 19, 2022

Completed
1.1 years until next milestone

First Posted

Study publicly available on registry

September 13, 2023

Completed
Last Updated

September 13, 2023

Status Verified

August 1, 2022

Enrollment Period

1.2 years

First QC Date

August 19, 2022

Last Update Submit

September 11, 2023

Conditions

Keywords

salivary tumorsdiagnostic accuracyFine Needle Aspiration

Outcome Measures

Primary Outcomes (1)

  • Diagnostic accuracy of Fine Needle Aspiration in salivary tumors

    The result FNA of salivary tumor was compared to (verified) Histologic result after tumor resection. Then Diagnostic accuracy of FNA was estimated.

    Every patient underwent FNA in a time frame from 1 day to 1 month before the surgical resection of the tumor. Then, under general anesthesia the tumor was surgicaly resected and was immediately examined to the Histology Laboratory of the Hospital.

Study Arms (1)

patients with salivary gland tumors

patients with salivary gland tumors

Diagnostic Test: Fine Needle AspirationProcedure: Histologic Examination

Interventions

Fine Needle AspirationDIAGNOSTIC_TEST

Fine Needle Aspiration of a salivary gland tumor

Also known as: FNA
patients with salivary gland tumors

Histologic examination of resected salivary tumor

patients with salivary gland tumors

Eligibility Criteria

Age24 Years - 96 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult patients with salivary tumors that examined in outpatient Oral and Maxillofacial Surgery Clinic of Anti-Cancer Hospital of Thessaloniki "Theageneio" and General Hospital of Thessaloniki "G. Papanikolaou".

You may qualify if:

  • Adult patients \>=18 years
  • salivary tumor suspected
  • FNA result available
  • Salivary tumor surgically resected
  • Histologic result available

You may not qualify if:

  • Patients under 18 years old
  • FNA result or Histologic result not available
  • No tumor resection
  • Other neck tumors (not salivary tumor)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aristotle University

Thessaloniki, 54124, Greece

Location

MeSH Terms

Conditions

Salivary Gland NeoplasmsDisease

Interventions

Biopsy, Fine-NeedleHistological Techniques

Condition Hierarchy (Ancestors)

Mouth NeoplasmsHead and Neck NeoplasmsNeoplasms by SiteNeoplasmsMouth DiseasesStomatognathic DiseasesSalivary Gland DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Biopsy, NeedleBiopsyCytodiagnosisCytological TechniquesClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisSpecimen HandlingDiagnostic Techniques, SurgicalSurgical Procedures, OperativePuncturesInvestigative Techniques

Study Officials

  • Theodoros V. Grivas, Medical

    Aristotle University Thessaloniki

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 19, 2022

First Posted

September 13, 2023

Study Start

February 22, 2021

Primary Completion

May 15, 2022

Study Completion

June 6, 2022

Last Updated

September 13, 2023

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will share

SN,Sex,Clinic of Origin,Date of Birth,Age, Final Result of FNA (as included in Excel database),Histological result (as included in Excel database) are available to all researchers.

Time Frame
Immediatelly available and for 6 months
Access Criteria
The excel database with the menioned individual participant data (IPD) can be available only for academical reason after email verification

Locations